These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

468 related items for PubMed ID: 22334252

  • 1. Development of ascites in compensated cirrhosis with severe portal hypertension treated with β-blockers.
    Hernández-Gea V, Aracil C, Colomo A, Garupera I, Poca M, Torras X, Miñana J, Guarner C, Villanueva C.
    Am J Gastroenterol; 2012 Mar; 107(3):418-27. PubMed ID: 22334252
    [Abstract] [Full Text] [Related]

  • 2. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
    Ripoll C, Groszmann R, Garcia-Tsao G, Grace N, Burroughs A, Planas R, Escorsell A, Garcia-Pagan JC, Makuch R, Patch D, Matloff DS, Bosch J, Portal Hypertension Collaborative Group.
    Gastroenterology; 2007 Aug; 133(2):481-8. PubMed ID: 17681169
    [Abstract] [Full Text] [Related]

  • 3. Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding.
    Villanueva C, Aracil C, Colomo A, Hernández-Gea V, López-Balaguer JM, Alvarez-Urturi C, Torras X, Balanzó J, Guarner C.
    Gastroenterology; 2009 Jul; 137(1):119-28. PubMed ID: 19344721
    [Abstract] [Full Text] [Related]

  • 4. [Measurement of hepatic venous pressure gradient in liver cirrhosis: relationship with the status of cirrhosis, varices, and ascites in Korea].
    Kim MY, Baik SK, Suk KT, Yea CJ, Lee IY, Kim JW, Cha SH, Kim YJ, Um SH, Han KH.
    Korean J Hepatol; 2008 Jun; 14(2):150-8. PubMed ID: 18617762
    [Abstract] [Full Text] [Related]

  • 5. Development of hyperdynamic circulation and response to β-blockers in compensated cirrhosis with portal hypertension.
    Villanueva C, Albillos A, Genescà J, Abraldes JG, Calleja JL, Aracil C, Bañares R, Morillas R, Poca M, Peñas B, Augustin S, Garcia-Pagan JC, Pavel O, Bosch J.
    Hepatology; 2016 Jan; 63(1):197-206. PubMed ID: 26422126
    [Abstract] [Full Text] [Related]

  • 6. Clinical significance of worsening portal hypertension during long-term medical treatment in patients with cirrhosis who had been classified as early good-responders on haemodynamic criteria.
    Merkel C, Bolognesi M, Berzigotti A, Amodio P, Cavasin L, Casarotto IM, Zoli M, Gatta A.
    J Hepatol; 2010 Jan; 52(1):45-53. PubMed ID: 19914730
    [Abstract] [Full Text] [Related]

  • 7. Prognostic value of acute hemodynamic response to i.v. propranolol in patients with cirrhosis and portal hypertension.
    La Mura V, Abraldes JG, Raffa S, Retto O, Berzigotti A, García-Pagán JC, Bosch J.
    J Hepatol; 2009 Aug; 51(2):279-87. PubMed ID: 19501930
    [Abstract] [Full Text] [Related]

  • 8. β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial.
    Villanueva C, Albillos A, Genescà J, Garcia-Pagan JC, Calleja JL, Aracil C, Bañares R, Morillas RM, Poca M, Peñas B, Augustin S, Abraldes JG, Alvarado E, Torres F, Bosch J.
    Lancet; 2019 Apr 20; 393(10181):1597-1608. PubMed ID: 30910320
    [Abstract] [Full Text] [Related]

  • 9. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis.
    Groszmann RJ, Garcia-Tsao G, Bosch J, Grace ND, Burroughs AK, Planas R, Escorsell A, Garcia-Pagan JC, Patch D, Matloff DS, Gao H, Makuch R, Portal Hypertension Collaborative Group.
    N Engl J Med; 2005 Nov 24; 353(21):2254-61. PubMed ID: 16306522
    [Abstract] [Full Text] [Related]

  • 10. Preventing the development of varices in cirrhosis.
    Garcia-Tsao G.
    J Clin Gastroenterol; 2007 Nov 24; 41 Suppl 3():S300-4. PubMed ID: 17975480
    [Abstract] [Full Text] [Related]

  • 11. Right atrial pressure is not adequate to calculate portal pressure gradient in cirrhosis: a clinical-hemodynamic correlation study.
    La Mura V, Abraldes JG, Berzigotti A, Erice E, Flores-Arroyo A, García-Pagán JC, Bosch J.
    Hepatology; 2010 Jun 24; 51(6):2108-16. PubMed ID: 20512998
    [Abstract] [Full Text] [Related]

  • 12. von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis.
    Ferlitsch M, Reiberger T, Hoke M, Salzl P, Schwengerer B, Ulbrich G, Payer BA, Trauner M, Peck-Radosavljevic M, Ferlitsch A.
    Hepatology; 2012 Oct 24; 56(4):1439-47. PubMed ID: 22532296
    [Abstract] [Full Text] [Related]

  • 13. Liver stiffness accurately predicts portal hypertension related complications in patients with chronic liver disease: a prospective study.
    Robic MA, Procopet B, Métivier S, Péron JM, Selves J, Vinel JP, Bureau C.
    J Hepatol; 2011 Nov 24; 55(5):1017-24. PubMed ID: 21354450
    [Abstract] [Full Text] [Related]

  • 14. Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis.
    Abraldes JG, Tarantino I, Turnes J, Garcia-Pagan JC, Rodés J, Bosch J.
    Hepatology; 2003 Apr 24; 37(4):902-8. PubMed ID: 12668985
    [Abstract] [Full Text] [Related]

  • 15. Editorial: Beta-blockers and the prevention of decompensation in cirrhosis: worth the trouble.
    Northup PG, Henry ZH.
    Am J Gastroenterol; 2012 Mar 24; 107(3):428-30. PubMed ID: 22388023
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Maintenance of hemodynamic response to treatment for portal hypertension and influence on complications of cirrhosis.
    Villanueva C, López-Balaguer JM, Aracil C, Kolle L, González B, Miñana J, Soriano G, Guarner C, Balanzó J.
    J Hepatol; 2004 May 24; 40(5):757-65. PubMed ID: 15094222
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.